COVID-19 review shows that benefits of vaccinating children and adolescents appear to outweigh risks of post-vaccination myopericarditis.
Rosa MorelloMara PepeLaura MartinoIlaria LazzareschiAntonio ChiarettiAntonio GattoAntonietta CuratolaPublished in: Acta paediatrica (Oslo, Norway : 1992) (2022)
The benefits of COVID-19 vaccination in children and adolescents appear to outweigh the risk of developing post-vaccination myopericarditis. We can also speculate a possible approval of vaccination in children under 5 years for the coming winter.